{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:03:00Z","timestamp":1791068580262,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00228-019-02800-3","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T09:03:30Z","timestamp":1577091810000},"page":"383-391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":112,"title":["Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers"],"prefix":"10.1007","volume":"76","author":[{"given":"Xiao-yan","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-e","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4186-1005","authenticated-orcid":false,"given":"Yi-min","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,23]]},"reference":[{"issue":"2","key":"2800_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bpa.2018.06.007","volume":"32","author":"EM Cornett","year":"2018","unstructured":"Cornett EM, Novitch MB, Brunk AJ, Davidson KS, Menard BL, Urman RD, Kaye AD (2018) New benzodiazepines for sedation. Best Pract Res Clin Anaesthesiol 32(2):149\u2013164. https:\/\/doi.org\/10.1016\/j.bpa.2018.06.007","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"1","key":"2800_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1124\/pr.110.002717","volume":"63","author":"TI Saari","year":"2011","unstructured":"Saari TI, Uusi-Oukari M, Ahonen J, Olkkola KT (2011) Enhancement of GABAergic activity: neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology. Pharmacol Rev 63(1):243\u2013267. https:\/\/doi.org\/10.1124\/pr.110.002717","journal-title":"Pharmacol Rev"},{"key":"2800_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-3-540-74806-9_16","volume":"182","author":"KT Olkkola","year":"2008","unstructured":"Olkkola KT, Ahonen J (2008) Midazolam and other benzodiazepines. Handb Exp Pharmacol 182:335\u2013360. https:\/\/doi.org\/10.1007\/978-3-540-74806-9_16","journal-title":"Handb Exp Pharmacol"},{"issue":"3","key":"2800_CR4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/00000542-198503000-00017","volume":"62","author":"JG Reves","year":"1985","unstructured":"Reves JG, Fragen RJ, Vinik HR, Greenblatt DJ (1985) Midazolam: pharmacology and uses. Anesthesiology 62(3):310\u2013324","journal-title":"Anesthesiology"},{"issue":"1","key":"2800_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.chest.2018.09.015","volume":"155","author":"NJ Pastis","year":"2019","unstructured":"Pastis NJ, Yarmus LB, Schippers F, Ostroff R, Chen A, Akulian J, Wahidi M, Shojaee S, Tanner NT, Callahan SP, Feldman G, Lorch DG Jr, Ndukwu I, Pritchett MA, Silvestri GA, Investigators PAION (2019) Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy. Chest 155(1):137\u2013146. https:\/\/doi.org\/10.1016\/j.chest.2018.09.015","journal-title":"Chest"},{"issue":"6","key":"2800_CR6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1542-3565(03)00226-X","volume":"1","author":"BJ Ulmer","year":"2003","unstructured":"Ulmer BJ, Hansen JJ, Overley CA, Symms MR, Chadalawada V, Liangpunsakul S, Strahl E, Mendel AM, Rex DK (2003) Propofol versus midazolam\/fentanyl for outpatient colonoscopy: administration by nurses supervised by endoscopists. Clin Gastroenterol Hepatol 1(6):425\u2013432","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2800_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tgie.2016.02.004","volume":"18","author":"DJ Pambianco","year":"2016","unstructured":"Pambianco DJ, Cash BD (2016) New horizons for sedation: the ultrashort acting benzodiazepine remimazolam. Tech Gastrointest Endosc 18(1):22\u201328. https:\/\/doi.org\/10.1016\/j.tgie.2016.02.004","journal-title":"Tech Gastrointest Endosc"},{"issue":"12","key":"2800_CR8","first-page":"929","volume":"13","author":"WK Rogers","year":"2010","unstructured":"Rogers WK, McDowell TS (2010) Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and\/or anesthesia in day-case surgical and non-surgical procedures. IDrugs 13(12):929\u2013937","journal-title":"IDrugs"},{"issue":"3","key":"2800_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.4103\/1658-354X.136627","volume":"8","author":"BG Goudra","year":"2014","unstructured":"Goudra BG, Singh PM (2014) Remimazolam: the future of its sedative potential. Saudi J Anaesth 8(3):388\u2013391. https:\/\/doi.org\/10.4103\/1658-354X.136627","journal-title":"Saudi J Anaesth"},{"issue":"1","key":"2800_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/01.anes.0000267503.85085.c0","volume":"107","author":"GJ Kilpatrick","year":"2007","unstructured":"Kilpatrick GJ, McIntyre MS, Cox RF, Stafford JA, Pacofsky GJ, Lovell GG, Wiard RP, Feldman PL, Collins H, Waszczak BL, Tilbrook GS (2007) CNS 7056: a novel ultra-short-acting benzodiazepine. Anesthesiology 107(1):60\u201366","journal-title":"Anesthesiology"},{"issue":"9","key":"2800_CR11","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/phar.1806","volume":"36","author":"AM Wesolowski","year":"2016","unstructured":"Wesolowski AM, Zaccagnino MP, Malapero RJ, Kaye AD, Urman RD (2016) Remimazolam: pharmacologic considerations and clinical role in anesthesiology. Pharmacotherapy 36(9):1021\u20131027. https:\/\/doi.org\/10.1002\/phar.1806","journal-title":"Pharmacotherapy"},{"key":"2800_CR12","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.3389\/fphar.2018.01316","volume":"9","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Hu P, Huang Y, Nuoer S, Song K, Wang H, Wen J, Jiang J, Chen X (2018) Population pharmacokinetic\/pharmacodynamic model-guided dosing optimization of a novel sedative HR7056 in Chinese healthy subjects. Front Pharmacol 9:1316. https:\/\/doi.org\/10.3389\/fphar.2018.01316","journal-title":"Front Pharmacol"},{"issue":"2","key":"2800_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1213\/ANE.0b013e31823f0c28","volume":"115","author":"LJ Antonik","year":"2012","unstructured":"Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM (2012) A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. safety, efficacy, and basic pharmacokinetics. Anesth Analg 115(2):274\u2013283. https:\/\/doi.org\/10.1213\/ANE.0b013e31823f0c28","journal-title":"Anesth Analg"},{"issue":"2","key":"2800_CR14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1213\/ANE.0b013e318241f68a","volume":"115","author":"HR Wiltshire","year":"2012","unstructured":"Wiltshire HR, Kilpatrick GJ, Tilbrook GS, Borkett KM (2012) A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part II. Population pharmacokinetic and pharmacodynamic modeling and simulation. Anesth Analg 115(2):284\u2013296. https:\/\/doi.org\/10.1213\/ANE.0b013e318241f68a","journal-title":"Anesth Analg"},{"issue":"5","key":"2800_CR15","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1213\/ANE.0b013e3182a705ae","volume":"117","author":"MT Worthington","year":"2013","unstructured":"Worthington MT, Antonik LJ, Goldwater DR, Lees JP, Wilhelm-Ogunbiyi K, Borkett KM, Mitchell MC (2013) A phase Ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopy. Anesth Analg 117(5):1093\u20131100. https:\/\/doi.org\/10.1213\/ANE.0b013e3182a705ae","journal-title":"Anesth Analg"},{"issue":"4","key":"2800_CR16","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1213\/ANE.0000000000000548","volume":"120","author":"KM Borett","year":"2015","unstructured":"Borett KM, Riff DS, Schwartz HI, Winkle PJ, Pambianco DJ, Lees JP, Wilhelm-Ogunbiyi K (2015) A phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy. Anesth Analg 120(4):771\u2013780. https:\/\/doi.org\/10.1213\/ANE.0000000000000548","journal-title":"Anesth Analg"},{"issue":"5","key":"2800_CR17","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.gie.2015.08.062","volume":"83","author":"DJ Pambianco","year":"2016","unstructured":"Pambianco DJ, Borkett KM, Riff DS, Winkle PJ, Schwartz HI, Melson TI, Wilhelm-Ogunbiyi K (2016) A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy. Gastrointest Endosc 83(5):984\u2013992. https:\/\/doi.org\/10.1016\/j.gie.2015.08.062","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"2800_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.gie.2018.04.2351","volume":"88","author":"DK Rex","year":"2018","unstructured":"Rex DK, Bhandari R, Desta T, DeMicco MP, Schaeffer C, Etzkorn K, Barish CF, Pruitt R, Cash BD, Quirk D, Tiongco F, Sullivan S, Bernstein D (2018) A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc 88(3):427\u2013437. https:\/\/doi.org\/10.1016\/j.gie.2018.04.2351","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"2800_CR19","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1067\/mge.2000.107284","volume":"52","author":"AL Bower","year":"2000","unstructured":"Bower AL, Ripepi A, Dilger J, Boparai N, Brody FJ, Ponsky JL (2000) Bispectral index monitoring of sedation during endoscopy. Gastrointest Endosc 52(2):192\u2013196","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"2800_CR20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00004714-199008000-00003","volume":"10","author":"DA Chernik","year":"1990","unstructured":"Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB, Schwam EM, Siegel JL (1990) Validity and reliability of the observer\u2019s assessment of alertness\/sedation scale: study with intravenous midazolam. J Clin Psychopharmacol 10(4):244\u2013251","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"2800_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/ALN.0b013e3181ae8460","volume":"111","author":"TD Egan","year":"2009","unstructured":"Egan TD (2009) Is anesthesiology going soft? Trends in fragile pharmacology. Anesthesiology 111(2):229\u2013230. https:\/\/doi.org\/10.1097\/ALN.0b013e3181ae8460","journal-title":"Anesthesiology"},{"issue":"4","key":"2800_CR22","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1097\/00000542-200004000-00016","volume":"92","author":"H Ericsson","year":"2000","unstructured":"Ericsson H, Bredberg U, Eriksson U, Jolin-Mellg\u00e5rd A, Nordlander M, Reg\u00e5rdh CG (2000) Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteers. Anesthesiology 92(4):993\u20131001. https:\/\/doi.org\/10.1097\/00000542-200004000-00016","journal-title":"Anesthesiology"},{"issue":"4","key":"2800_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0928-0987(01)00180-4","volume":"14","author":"L Sun","year":"2001","unstructured":"Sun L, Lau CE (2001) Arteriovenous serum cocaine concentration difference after intravenous bolus injection and constant-rate infusions: relation to pharmacodynamic estimates in rats. Eur J Pharm Sci 14(4):261\u2013269","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"2800_CR24","first-page":"202","volume":"284","author":"B Tuk","year":"1998","unstructured":"Tuk B, Herben VM, Mandema JW, Danhof M (1998) Relevance of arteriovenous concentration differences in pharmacokinetic-pharmacodynamic modeling of midazolam. J Pharmacol Exp Ther 284(1):202\u2013207","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"2800_CR25","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1213\/ANE.0b013e3181e5e8af","volume":"111","author":"E Olofsen","year":"2010","unstructured":"Olofsen E, Mooren R, van Dorp E, Aarts L, Smith T, den Hartigh J, Dahan A, Sarton E (2010) Arterial and venous pharmacokinetics of morphine-6-glucuronide and impact of sample site on pharmacodynamic parameter estimates. Anesth Analg 111(3):626\u2013632. https:\/\/doi.org\/10.1213\/ANE.0b013e3181e5e8af","journal-title":"Anesth Analg"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02800-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02800-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02800-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:10:10Z","timestamp":1608595810000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02800-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,23]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["2800"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02800-3","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,23]]},"assertion":[{"value":"7 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Li-e Li and Xia Ye are employees of Yichang Humanwell Pharmaceutical Co., Ltd., which sponsored the clinical trial. The other authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}